Video

Episode 15- Assessing the Factors at Increased Risk for Cardiometabolic Events

When assessing what population is at an increased risk for developing a cardiometabolic event, Kenneth L. Schaecher, MD, FACP, CPC, explains that the patient who is disengaged is at the greatest risk. Dr Schaecher states that patients who do not make lifestyle changes and patients who are not adherent to their medicines are examples of disengaged patients.

Furthermore, the panelists discuss the cardiometabolic conditions that result in the greatest costs to managed care facilities. Dr Schaecher explains that diabetes is number 1.

Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that while commonly overlooked, kidney disease is also a component of cardiovascular disease (CVD). Dr Handelsman believes that the outcomes of kidney disease pass beyond diabetes, but the condition is commonly overlooked because less patients present with kidney disease than diabetes.

Dr Schaecher concludes that patients need to have a better understanding of how kidney disease links to cardiometabolic events.


Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
Eileen Peng, PharmD, sitting for a video interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo